Since 1997 there has been a cumulative investment of €400 million in the development of cancer services, well in excess of the £25 million initially envisaged in 1996 to implement the national cancer strategy. This funding includes an additional €29 million allocated in 2003 for cancer services this year. That investment will ensure that this year we continue to address increasing demands in cancer services in areas such as oncology/haematology services, oncology drugs and symptomatic breast disease services. This substantial investment has enabled the funding of 80 additional consultant posts, together with support staff in key areas such as medical oncology, radiology, palliative care, histopathology and haematology.